1-11 of 11
Annie Borel-Derlon, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Who Are the Type 2 Von Willebrand Disease Patients? Results from Interim Analysis of the French HRQoL Study: Wish-Qol .

Annie Borel-Derlon, MD PhD, Jenny Goudemand, MD PhD, Dominique Desprez, MD, Céline Falaise, Fabienne Genre Volot, MD, Laurent Ardillon, MD, Brigitte Pan-Petesch, MD, Catherine Chatelanaz, Catherine Doriat-Robin, Agnès Veyradier, Sr., MD PhD, Sylvia Von Mackensen
Journal: Blood
Blood (2018) 132 (Supplement 1): 2468.
https://doi.org/10.1182/blood-2018-99-113289
Published: 2018
Journal Articles

Gastrointestinal Bleeding and Angiodysplasia in Von Willebrand Disease: Results from the Ongoing French HRQoL Study: Wish-Qol

Annie Borel-Derlon, MD PhD, Dominique Desprez, MD, Fabienne Volot, MD, Herve Chambost, MD PhD, Sophie Bayard, MD, Catherine Chatelanaz, Catherine Doriat-Robin, Yves Gruel, MD PhD, Agnès Veyradier, Sr., MD PhD, Jenny Goudemand, MD PhD, Sylvia Von Mackensen, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4866.
https://doi.org/10.1182/blood.V130.Suppl_1.4866.4866
Published: 2017
Journal Articles

Wish-Qol Study - Assessment of Health-Related Quality of Life (HRQoL) and Health-Economic Aspects in Patients with Von Willebrand Disease (VWD) in France: Results of the Women Cohort

Annie Borel-Derlon, MD PhD, Jenny Goudemand, MD PhD, Dominique Desprez, MD, Fabienne Volot, MD, Yves Gruel, MD, Sophie Bayard, MD, Catherine Chatelanaz, Catherine Doriat-Robin, Agnes Veyradier, MD PhD, Edith Fressinaud, MD, Sylvia von Mackensen, PhD
Journal: Blood
Blood (2016) 128 (22): 1395.
https://doi.org/10.1182/blood.V128.22.1395.1395
Published: 2016
Journal Articles

Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a Treated with Nuwiq ® , a New Generation Recombinant FVIII of Human Origin

Raina Liesner, Marina Abashidze, Olga Aleinikova, PhD, Carmen Altisent, PhD, Mark J. Belletrutti, MD MSc, Annie Borel-Derlon, MD PhD, Manuel Carcao, MD, Hervé Chambost, Anthony Chan, MBBS, FRCP(C), FRCPath, Leonid Dubey, MD PhD, Jonathan M. Ducore, Fouzia Nambiathayil Abubacker, DM, Michael Gattens, Yves Gruel, MD, Natalya Kavardakova, Mohamed Khorassani, Anna Klukowska, Christoph Königs, MD PhD, Thierry Lambert, Sunil Lohade, Marianne Sigaud, MD, Valentin Turea, John K. Wu, MBBS, MSc, FRCPC, Vladimir Vdovin
Journal: Blood
Blood (2016) 128 (22): 327.
https://doi.org/10.1182/blood.V128.22.327.327
Published: 2016
Journal Articles

Treatment of Von Willebrand Disease Women Undergoing Childbirth with a Von Willebrand Factor Product with a Low Content of Factor VIII: Results From 4 Multicenter Studies

Catherine Boyer-Neumann, Annie Borel-Derlon, MD, PhD, Jenny Goudemand, MD, PhD, Ségolène Claeyssens, Pierre-Marie Sie, MD, PhD, Philippe Moreau, Marie-Anne Bertrand, MD, Chantal Rothschild, MD, Benoît Guillet, MD, PhD, Jeanne Yvonne Borg, Catherine Chatelanaz, Wil Stevens, Françoise Bridey, Celine Henriet
Journal: Blood
Blood (2012) 120 (21): 3375.
https://doi.org/10.1182/blood.V120.21.3375.3375
Published: 2012
Journal Articles

Development of Inhibitory Antibodies to Therapeutic Factor VIII in Severe Hemophilia A Is Associated with Microsatellite Polymorphism in the HMOX1 promoter

Yohann Repesse, PhD, Ivan Peyron, Jordan Dimitrov, PhD, Suryasarathi Dasgupta, PhD, Elika Farrokhi Moshai, Annie Borel-Derlon, MD, PhD, Catherine Costa, MD, Benoist Guillet, MD, PhD, Roseline d'Oiron, MD, Achille Aouba, MD, Chantal Rothschild, MD, Johannes Oldenburg, MD, Ana Pavlova, MD, Srinivas Kaveri, D. V. M., Ph.D, Sebastien Lacroix-Desmazes, PhD
Journal: Blood
Blood (2012) 120 (21): 38.
https://doi.org/10.1182/blood.V120.21.38.38
Published: 2012
Journal Articles

Clinical Use of a Von Willebrand Factor with a Low FVIII Content in Von Willebrand Disease Patients Undergoing Surgical Procedures or Deliveries: Results From 5 Prospective Multicenter Studies

Annie Borel-Derlon, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Catherine Chatelanaz, Celine Henriet, Françoise Bridey
Journal: Blood
Blood (2011) 118 (21): 383.
https://doi.org/10.1182/blood.V118.21.383.383
Published: 2011
Journal Articles

Presence and Evolution of a Catalytic Activity in Patients with Severe, Mild or Moderate Hemophilia A

Sandrine Grosbois, PhD, Marie François-Brionne, Elise Vallée, Philippe Gautier, MD, Yohann Repesse, PhD, Annie Borel-Derlon, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1211.
https://doi.org/10.1182/blood.V118.21.1211.1211
Published: 2011
Journal Articles

Environmental Risk Factors of Inhibitor in Mild/Moderate Hemophilia A Patients Included in the FranceCoag Network

Roseline d'Oiron, MD, Virginie Demiguel, MSc, Annie Borel-Derlon, MD, PhD, Ségolène Donadel-Claeyssens, MD, PhD, Jenny Goudemand, MD, PhD, Benoît Guillet, MD, PhD, Yves Gruel, MD, PhD, Valérie Roussel-Robert, MD, Fabienne Volot, MD, Thierry Calvez, MD, MSc
Journal: Blood
Blood (2011) 118 (21): 1213.
https://doi.org/10.1182/blood.V118.21.1213.1213
Published: 2011
Journal Articles

Inhibitor Development In Patients with Mild and Moderate Hemophilia A: Results From a Single Centre.

Yohann Repesse, Philippe Gautier, Annie Borel-Derlon, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1407.
https://doi.org/10.1182/blood.V116.21.1407.1407
Published: 2010
Journal Articles

Prophylactic Use of rFVIIa in a Young Hemophilia A Patient with Factor VIII Inhibitor.

Annie Borel-Derlon, MD, PhD, Mounia Slaoui, MD, Philippe Gautier, MD, Patricia Guillon
Journal: Blood
Blood (2005) 106 (11): 4068.
https://doi.org/10.1182/blood.V106.11.4068.4068
Published: 2005